Literature DB >> 1427654

Emergency liver transplantation for fulminant liver failure in infants and children.

D Devictor1, L Desplanques, D Debray, Y Ozier, A M Dubousset, J Valayer, D Houssin, O Bernard, G Huault.   

Abstract

We report our results with orthotopic liver transplantation in children with fulminant liver failure. Thirty-five children with fulminant liver failure were evaluated for liver transplantation. The main causes of liver failure were viral hepatitis (54.2%), drug-induced liver injury (14.2%) and Wilson's disease (11.4%). Children were considered as candidates for liver transplantation only if hepatic encephalopathy was associated with a decrease in the level of factor V to below 25%. Seven children (20%) did not meet this criterion and recovered spontaneously. Six children (17.1%) had contraindications for liver transplantation and died. In three of these six children, contraindications included irreversible brain damage at the time of admission. Twenty-two children (62.8%) met the criteria for liver transplantation and were placed on the emergency transplant list. Three of them died awaiting grafts. Nineteen children underwent liver transplantation; 13 of them (68.4%) are alive without sequelae, after 6 mo to 4 yr of follow-up, at this writing. Four of the children who died after surgery had severe encephalopathy on admission that did not improve after liver transplantation. In conclusion, emergency liver transplantation appears to be an effective treatment for children with fulminant liver failure. Nevertheless, irreversible brain damage developed in 10 patients, and they died before or after surgery. We postulate that many of these deaths could have been avoided if children had been transferred to a liver transplantation facility and had undergone transplantation earlier. We emphasize that children with acute liver failure should be transferred to a center that performs liver transplantation before the development of hepatic encephalopathy.

Entities:  

Mesh:

Year:  1992        PMID: 1427654

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Liver transplantation and artificial liver support in fulminant hepatic failure.

Authors:  X F Zhu; G H Chen; X S He; M Q Lu; G D Wang; C J Cai; Y Yang; J F Huang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study.

Authors:  V Roger; P Balladur; J Honiger; M Baudrimont; R Delelo; A Robert; Y Calmus; J Capeau; B Nordlinger
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

3.  Analysis of viral testing in nonacetaminophen pediatric acute liver failure.

Authors:  Kathleen B Schwarz; Dominic Dell Olio; Steven J Lobritto; M James Lopez; Norberto Rodriguez-Baez; Nada A Yazigi; Steven H Belle; Song Zhang; Robert H Squires
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-11       Impact factor: 2.839

4.  Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group.

Authors:  Robert H Squires; Benjamin L Shneider; John Bucuvalas; Estella Alonso; Ronald J Sokol; Michael R Narkewicz; Anil Dhawan; Philip Rosenthal; Norberto Rodriguez-Baez; Karen F Murray; Simon Horslen; Martin G Martin; M James Lopez; Humberto Soriano; Brendan M McGuire; Maureen M Jonas; Nada Yazigi; Ross W Shepherd; Kathleen Schwarz; Steven Lobritto; Daniel W Thomas; Joel E Lavine; Saul Karpen; Vicky Ng; Deirdre Kelly; Nancy Simonds; Linda S Hynan
Journal:  J Pediatr       Date:  2006-05       Impact factor: 4.406

Review 5.  Quality of life after orthotopic liver transplantation in children. An overview of physical, psychological and social outcome.

Authors:  E M Sokal
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

6.  King's College Hospital Criteria for non-acetaminophen induced acute liver failure in an international cohort of children.

Authors:  Vinay Sundaram; Benjamin L Shneider; Anil Dhawan; Vicky L Ng; Kyungah Im; Steven Belle; Robert H Squires
Journal:  J Pediatr       Date:  2012-08-18       Impact factor: 4.406

7.  Liver transplantation for fulminant hepatitis at Stanford University.

Authors:  Amy Lu; Humberto Monge; Kenneth Drazan; Maria Millan; Carlos O Esquivel
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  Fulminant hepatic failure in a child as a potential adverse effect of trimethoprim-sulphamethoxazole.

Authors:  B Simma; B Meister; J Deutsch; W Sperl; F Fend; D Ofner; R Margreiter; W Vogel
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

9.  Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.

Authors:  Douglas G Farmer; Dean M Anselmo; R Mark Ghobrial; Hasan Yersiz; Suzanne V McDiarmid; Carlos Cao; Michael Weaver; Jesus Figueroa; Khurram Khan; Jorge Vargas; Sammy Saab; Steven Han; Francisco Durazo; Leonard Goldstein; Curtis Holt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

10.  A surveillance method for the early identification of idiosyncratic adverse drug reactions.

Authors:  Fatma A Etwel; Michael J Rieder; John R Bend; Gideon Koren
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.